Weight-loss drug tirzepatide shows promise for post-surgery weight regain
NCT ID NCT07382180
First seen Feb 02, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looked at how the drug tirzepatide works in real-world settings for two groups: people who regained weight after bariatric surgery and people with obesity preparing for surgery. Researchers tracked weight and health changes over six months in 254 adults. The goal was to see if tirzepatide helps control weight as part of routine care, not as a cure but as an ongoing management tool.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, MORBID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Head of bariatric surgery
Naples, 80131, Italy
Conditions
Explore the condition pages connected to this study.